Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides
JAMA Neurol
.
2016 Dec 1;73(12):1502.
doi: 10.1001/jamaneurol.2016.4332.
Author
Satyakam Bhagavati
1
Affiliation
1
Downstate Medical Center, State University of New York, Brooklyn.
PMID:
27802491
DOI:
10.1001/jamaneurol.2016.4332
No abstract available
Publication types
Letter
Comment
MeSH terms
Genetic Therapy
Humans
Nervous System Diseases*
Oligonucleotides, Antisense*
Substances
Oligonucleotides, Antisense